RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause recurring, miserable bouts of diarrhea. Reading time 3 minutes We might soon have a ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

Specifically, the team tested whether mRNA technology could be used to protect against the damage inflicted by the venom of ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and ...

As pharma giants including Moderna and Pfizer and BioNTech make breakthroughs in their COVID-19 vaccine developments, healthcare officials are facing tech and data challenges associated with ...

Mycobacterium tuberculosis (Public Health Image Library, NIAID, Image ID: 18139) Mycobacterium tuberculosis (Public Health Image Library, NIAID, Image ID: 18139) Tuberculosis (TB) is the number one ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving COVID shots. There's a catch: The mRNA technology ...

Health Secretary Robert F. Kennedy Jr.’s decision to cancel $500 million in grants and contracts for mRNA vaccine development jeopardizes the health and safety of Americans; both now and for years to ...